SCHEMBL30289129

SCHEMBL30289129

Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(N3CCN(C(=O)CCN4CCC(NC(=O)OC(C)(C)C)CC4)CC3)cc21

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 12/20 0.45
DDB1 Q16531 10/20 0.45
KCNA3 P22001 1/20 0.39
IRAK1 P51617 2/20 0.38
IRAK4 Q9NWZ3 2/20 0.38
IRAK3 Q9Y616 2/20 0.38
CCNC P24863 1/20 0.38
CDK8 P49336 1/20 0.38
NTRK3 Q16288 1/20 0.38
HASPIN Q8TF76 1/20 0.38
CDK19 Q9BWU1 1/20 0.38
USP14 P54578 1/20 0.36
DRD2 P14416 2/20 0.36
DRD3 P35462 1/20 0.36
PIK3CA P42336 1/20 0.35
MTOR P42345 1/20 0.35
PRKDC P78527 1/20 0.35
ADAMTS5 Q9UNA0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30289037 0.94 DDB1 (0.46) CRBNDDB1KCNA3USP14DRD2
SCHEMBL31281758 0.90 CRBN (0.51) CRBNDDB1DRD2PIK3CAMTOR
SCHEMBL30289094 0.89 DDB1 (0.45) CRBNDDB1KCNA3DRD2PIK3CA
SCHEMBL30289436 0.85 CRBN (0.49) CRBNDDB1IRAK1IRAK4IRAK3
SCHEMBL30289475 0.84 DDB1 (0.56) CRBNDDB1KCNA3DRD2PIK3CA
SCHEMBL30288962 0.83 DDB1 (0.49) CRBNDDB1KCNA3DRD2PIK3CA
SCHEMBL30289264 0.83 DDB1 (0.57) CRBNDDB1KCNA3DRD2PIK3CA
SCHEMBL22835971 0.82 DDB1 (0.55) CRBNDDB1
SCHEMBL30768477 0.82 DDB1 (0.55) CRBNDDB1
SCHEMBL30768650 0.82 DDB1 (0.55) CRBNDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405359-A2 MDM2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-07-31 EP disclosed
WO-2023049790-A2 MDM2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-03-30 WO disclosed